Ramat Gan, Israel

Scott Alexander Sadler

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Anima Biotech Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Alexander Sadler. Retrieved from https://idiyas.com/inventor/scott-alexander-sadler-l58o479f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott Alexander Sadler: Innovator in Cancer Treatment

Introduction

Scott Alexander Sadler is a prominent inventor based in Ramat Gan, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on novel approaches to modulate mRNA translation, which has the potential to revolutionize cancer therapies.

Latest Patents

Scott holds a patent for "c-MYC mRNA translation modulators and uses thereof in the treatment of cancer." This invention relates to novel c-MYC mRNA translation modulators, compositions, and methods of preparation, as well as their applications in treating cancer. His patent portfolio includes 1 patent that showcases his commitment to advancing medical science.

Career Highlights

Throughout his career, Scott has been associated with Anima Biotech Inc., a company dedicated to developing innovative therapies based on mRNA biology. His work at Anima Biotech has positioned him as a key player in the biotechnology sector, particularly in the realm of cancer research.

Collaborations

Scott has collaborated with notable colleagues, including Aviad Mandabi and Boaz Inbal. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking treatments.

Conclusion

Scott Alexander Sadler is a visionary inventor whose work in mRNA translation modulation holds promise for the future of cancer treatment. His contributions to the field exemplify the impact of innovative research on healthcare advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…